VITA 34 AG (V3V.DE)
EUR 4.28
(2.88%)
EUR 4.28
(2.88%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 4.15 Million EUR | -65.02% |
| 2022 | 11.89 Million EUR | 1485.78% |
| 2021 | -858 Thousand EUR | 83.15% |
| 2020 | -5.09 Million EUR | -180.45% |
| 2019 | -1.81 Million EUR | -1125.99% |
| 2018 | 177 Thousand EUR | -95.56% |
| 2017 | 3.98 Million EUR | 694.93% |
| 2016 | -670 Thousand EUR | -194.77% |
| 2015 | 707 Thousand EUR | 120.32% |
| 2014 | -3.47 Million EUR | -35.0% |
| 2013 | -2.57 Million EUR | -89.9% |
| 2012 | -1.35 Million EUR | -958.86% |
| 2011 | 158 Thousand EUR | 18.8% |
| 2010 | 133 Thousand EUR | 103.68% |
| 2009 | -3.61 Million EUR | 23.88% |
| 2008 | -4.74 Million EUR | 51.81% |
| 2007 | -9.85 Million EUR | -385.71% |
| 2006 | -2.02 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 3.37 Million EUR | 12.11% |
| 2024 Q1 | 3 Million EUR | -27.7% |
| 2023 Q2 | 13.41 Million EUR | 9.01% |
| 2023 Q1 | 12.3 Million EUR | 3.52% |
| 2023 Q4 | 4.15 Million EUR | -70.42% |
| 2023 Q3 | 14.05 Million EUR | 4.78% |
| 2023 FY | 4.15 Million EUR | -65.02% |
| 2022 Q3 | 9.64 Million EUR | 78.15% |
| 2022 Q1 | 389 Thousand EUR | 145.34% |
| 2022 FY | 11.89 Million EUR | 1485.78% |
| 2022 Q2 | 5.41 Million EUR | 1291.77% |
| 2022 Q4 | 11.89 Million EUR | 23.28% |
| 2021 Q3 | -5.65 Million EUR | 8.67% |
| 2021 Q4 | -858 Thousand EUR | 84.84% |
| 2021 FY | -858 Thousand EUR | 83.15% |
| 2021 Q1 | -5.87 Million EUR | -15.28% |
| 2021 Q2 | -6.19 Million EUR | -5.52% |
| 2020 FY | -5.09 Million EUR | -180.45% |
| 2020 Q1 | -2.35 Million EUR | -29.68% |
| 2020 Q4 | -5.09 Million EUR | -6.91% |
| 2020 Q3 | -4.76 Million EUR | -29.18% |
| 2020 Q2 | -3.68 Million EUR | -56.6% |
| 2019 Q1 | 1.04 Million EUR | 489.83% |
| 2019 FY | -1.81 Million EUR | -1125.99% |
| 2019 Q3 | -1.23 Million EUR | -272.35% |
| 2019 Q2 | 716 Thousand EUR | -31.42% |
| 2019 Q4 | -1.81 Million EUR | -47.16% |
| 2018 Q4 | 177 Thousand EUR | -86.34% |
| 2018 Q3 | 1.29 Million EUR | -74.31% |
| 2018 Q2 | 5.04 Million EUR | 3.11% |
| 2018 Q1 | 4.89 Million EUR | 22.75% |
| 2018 FY | 177 Thousand EUR | -95.56% |
| 2017 Q1 | -482 Thousand EUR | 28.06% |
| 2017 Q4 | 3.98 Million EUR | 536.58% |
| 2017 Q3 | -913 Thousand EUR | -121.27% |
| 2017 Q2 | 4.29 Million EUR | 990.66% |
| 2017 FY | 3.98 Million EUR | 694.93% |
| 2016 Q2 | 1.05 Million EUR | 2.24% |
| 2016 Q4 | -670 Thousand EUR | -291.81% |
| 2016 FY | -670 Thousand EUR | -194.77% |
| 2016 Q3 | -171 Thousand EUR | -116.27% |
| 2016 Q1 | 1.02 Million EUR | 45.4% |
| 2015 Q1 | -4.27 Million EUR | -23.0% |
| 2015 Q2 | -1.08 Million EUR | 74.71% |
| 2015 Q3 | -469 Thousand EUR | 56.65% |
| 2015 Q4 | 707 Thousand EUR | 250.75% |
| 2015 FY | 707 Thousand EUR | 120.32% |
| 2014 Q2 | -3 Million EUR | 1.6% |
| 2014 Q3 | -4.17 Million EUR | -38.91% |
| 2014 Q4 | -3.47 Million EUR | 16.63% |
| 2014 Q1 | -3.05 Million EUR | -18.47% |
| 2014 FY | -3.47 Million EUR | -35.0% |
| 2013 Q4 | -2.57 Million EUR | -24.85% |
| 2013 FY | -2.57 Million EUR | -89.9% |
| 2013 Q1 | -1.35 Million EUR | 0.22% |
| 2013 Q2 | -1.56 Million EUR | -15.29% |
| 2013 Q3 | -2.06 Million EUR | -32.22% |
| 2012 Q2 | -142 Thousand EUR | -240.59% |
| 2012 Q1 | 101 Thousand EUR | -36.08% |
| 2012 Q3 | -932 Thousand EUR | -556.34% |
| 2012 FY | -1.35 Million EUR | -958.86% |
| 2012 Q4 | -1.35 Million EUR | -45.6% |
| 2011 Q2 | 990 Thousand EUR | -20.93% |
| 2011 Q1 | 1.25 Million EUR | 841.35% |
| 2011 Q4 | 158 Thousand EUR | 130.27% |
| 2011 FY | 158 Thousand EUR | 18.8% |
| 2011 Q3 | -522 Thousand EUR | -152.73% |
| 2010 Q4 | 133 Thousand EUR | -89.44% |
| 2010 Q1 | -3.67 Million EUR | -1.6% |
| 2010 FY | 133 Thousand EUR | 103.68% |
| 2010 Q2 | 1.4 Million EUR | 138.25% |
| 2010 Q3 | 1.25 Million EUR | -10.39% |
| 2009 Q2 | -3.01 Million EUR | 0.0% |
| 2009 Q4 | -3.61 Million EUR | 0.0% |
| 2009 FY | -3.61 Million EUR | 23.88% |
| 2008 FY | -4.74 Million EUR | 51.81% |
| 2007 FY | -9.85 Million EUR | -385.71% |
| 2006 FY | -2.02 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 10.64 Billion EUR | 99.961% |
| Fresenius SE & Co. KGaA | 13.54 Billion EUR | 99.969% |
| LIMES Schlosskliniken AG | 1.57 Million EUR | -164.709% |
| M1 Kliniken AG | -5.33 Million EUR | 177.932% |
| Maternus-Kliniken Aktiengesellschaft | 111.79 Million EUR | 96.28% |
| MEDICLIN Aktiengesellschaft | 364.53 Million EUR | 98.859% |
| RHÖN-KLINIKUM Aktiengesellschaft | -56.2 Million EUR | 107.4% |